Melissa Rutkin
Family · Doylestown, PANPI 1255008504
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $14,330 of the $18,266 with a category attached, or 78.5%. Insulet Corporation accounts for 79.0% of it on its own, with 28 other manufacturers making up the rest. 2025 is the largest year on record at $6,930, more than ten times the $214 reported in 2021. Among family clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 206 payments — averaging $88.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insulet Corporation$14K
- Medtronic$661
- Dexcom, Inc.$467
- Lilly USA, LLC$300
- Novo Nordisk$291
- Corcept Therapeutics$282
- plus $2K from 23 others
What the payments were for
- Speaking & faculty fees$14,33078%
- Food & beverage$3,92521%
- Education$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insulet Corporation | 47 | $14,437 |
| Medtronic | 17 | $661 |
| Dexcom, Inc. | 21 | $467 |
| Lilly USA, LLC | 18 | $300 |
| Novo Nordisk | 17 | $291 |
| Corcept Therapeutics | 13 | $282 |
| Amgen | 11 | $266 |
| BETA Bionics, Inc. | 5 | $249 |
| Boehringer Ingelheim | 7 | $168 |
| Tolmar, Inc. | 7 | $134 |
| Antares Pharma, Inc. | 5 | $126 |
| Tandem Diabetes Care, Inc. | 5 | $121 |
| Xeris Pharmaceuticals, Inc. | 6 | $103 |
| AbbVie | 5 | $93 |
| Abbott | 3 | $84 |
| Astellas Pharma US Inc | 2 | $61 |
| Recordati_rare_diseases_inc. | 2 | $55 |
| Sequel Med Tech, LLC | 2 | $51 |
| Novartis | 2 | $50 |
| Mannkind Corporation | 2 | $43 |
| Rhythm Pharmaceuticals, Inc. | 1 | $41 |
| Soleno Therapeutics, Inc. | 1 | $33 |
| Ascensia Diabetes Care US Inc. | 1 | $31 |
| Sanofi-aventis U.S. LLC | 1 | $29 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
| Sandoz | 1 | $20 |
| Madrigal Pharmaceuticals | 1 | $19 |
| IBSA Pharma Inc. | 1 | $18 |
| Vistapharm, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,266 in reported general payments places this provider in the 95th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 224 | $355,783 |
| JardianceEmpagliflozin | 110 | $112,379 |
| OzempicSemaglutide | 37 | $77,241 |
| JanuviaSitagliptin Phosphate | 33 | $45,652 |
| TrulicityDulaglutide | 37 | $44,235 |
| Tresiba Flextouch U-100Insulin Degludec | 19 | $18,987 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 13 | $18,088 |
| Novolog FlexpenInsulin Aspart | 35 | $13,144 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 64 | $10,530 |
| NovologInsulin Aspart | 20 | $7,281 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 49 | $6,490 |
| SynthroidLevothyroxine Sodium | 59 | $4,924 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $4,131 |
| Metformin Hcl ErMetformin Hcl | 78 | $2,266 |
| Levothyroxine Sodium | 96 | $1,571 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $300 | $400,018261 claims |
| Boehringer IngelheimJardiance | $168 | $112,379110 claims |
| Novo NordiskOzempic, Novolog | $291 | $84,52157 claims |
| AbbVieSynthroid | $93 | $4,92459 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $23 | $1,57196 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,717 family providers in Pennsylvania.
Other family in Doylestown
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
- Patricia HabdasPittsburgh$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.